MENU

NAMS NewAmsterdam Pharma Company NV Forecast, Technical & Fundamental Analysis

Industry Biotechnology
NAMS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
NAMS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

NAMS is expected to report earnings to rise 187.67% to -51 cents per share on March 28

NewAmsterdam Pharma Company NV NAMS Stock Earnings Reports
Q4'24
Est.
$-0.52
Q3'24
Beat
by $0.32
Q2'24
Beat
by $0.17
Q1'24
Missed
by $0.44
Q4'23
Beat
by $0.04
The last earnings report on November 06 showed earnings per share of -18 cents, beating the estimate of -49 cents. With 637.19K shares outstanding, the current market capitalization sits at 2.85B.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
Gooimeer 2-35
Phone
+31 352062971
Employees
29
Web
https://www.newamsterdampharma.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME31.261.82
+6.18%
GameStop Corp
TSLA479.8616.84
+3.64%
Tesla
AAPL253.482.44
+0.97%
Apple
BTC.X106140.600000110.890625
+0.10%
Bitcoin cryptocurrency
SPY604.29-2.50
-0.41%
SPDR® S&P 500® ETF Trust

NAMS and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, NAMS has been loosely correlated with CMRX. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if NAMS jumps, then CMRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NAMS
1D Price
Change %
NAMS100%
+7.69%
CMRX - NAMS
42%
Loosely correlated
-3.44%
QURE - NAMS
39%
Loosely correlated
-5.40%
GYRE - NAMS
31%
Poorly correlated
+11.31%
SPHDF - NAMS
31%
Poorly correlated
N/A
SLNCF - NAMS
24%
Poorly correlated
N/A
More